INTERNATIONAL PATENT: TARAN THERAPEUTICS, INC., THE UNIVERSITY OF ADELAIDE FILES APPLICATION FOR "COMBINATION TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN PATIENTS WITH RAS PATHWAY MUTATIONS"

GENEVA, May 15 -- TARAN THERAPEUTICS, INC. (5 Haines Cove DriveSuite 2Toms River, New Jersey 08753-6810), THE UNIVERSITY OF ADELAIDE (230 North TceAdelaide, South Australia 5005) filed a patent application (PCT/US2024/053765) for "COMBINATION TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN PATIENTS WITH RAS PATHWAY MUTATIONS" on Oct 30, 2024. With publication no. WO/2025/096692, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DURRANT, Cameron (9907 Bozzano DriveDelray Beach, Florida 33446), THOMAS, Daniel (c/o The Univers...